O型血是严重创伤后纤溶亢进与大量输血的风险因素
本研究在一级创伤中心回顾性纳入268例已知血型、现场收缩压<90 mm Hg的成人创伤激活患者,比较O型与非O型血对凝血指标、大量输血、无呼吸机天数和死亡率的影响。O型血患者纤溶亢进发生率43% vs 非O型29%(P=0.06),血管性血友病因子活性222% vs 249%(P=0.01)。校正新损伤严重度评分和钝性机制后,O型血纤溶亢进比值比1.94(95%CI 1.09-3.47),大量输血比值比3.02(95%CI 1.22-7.49)。其他结局无显著影响。作者认为这些发现对创伤后接受O型全血输注患者的纤溶亢进监测有启示。
要点
- O型血患者纤溶亢进发生率43% vs 非O型29%(P=0.06),校正新损伤严重度评分和钝性机制后OR 1.94(95%CI 1.09-3.47)。
- O型血患者大量输血校正后OR 3.02(95%CI 1.22-7.49)。
- O型血血管性血友病因子活性222% vs 非O型249%(P=0.01)。
- 无呼吸机天数与死亡率等其他结局无显著影响。
- 作者认为这些发现对创伤后接受O型全血输注患者的纤溶亢进监测有启示。
适用人群与场景
- 一级创伤中心已知血型的成人创伤激活患者,现场收缩压<90 mm Hg。
诊断标准与关键阈值
- 纤溶亢进定义为血栓弹力图30分钟裂解百分比>3%。
- 纤溶关闭定义为血栓弹力图30分钟裂解百分比<0.9%。
研究设计与关键结果
- 回顾性研究,共268例患者符合标准。
- O型血患者较非O型血更易发生纤溶亢进(43% vs 29%,P=0.06)。
- O型血患者血管性血友病因子活性显著更低(222% vs 249%,P=0.01),血管性血友病因子活性在212例受伤患者中用STAGO仪器定量。
- 校正新损伤严重度评分和钝性机制后,O型血纤溶亢进比值比1.94(95%CI 1.09-3.47)。
- 校正新损伤严重度评分和钝性机制后,O型血大量输血比值比3.02(95%CI 1.22-7.49)。
- 其他结局无显著影响。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现对创伤后接受O型全血输注患者的纤溶亢进监测有启示。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Blood type O is the most common blood type and has lower von Willebrand factor (vWF) levels (25%-35% lower than non-O blood types). von Willebrand factor is important for initiating platelet attachment and binding factor VIII. We hypothesized that patients with type O blood are at an increased risk of trauma-induced coagulopathy and bleeding post injury. Study Design: Adult trauma activations with known blood type at a level I trauma center with field systolic blood pressure < 90 mm Hg were studied retrospectively. The relationships of blood group O versus non-O to coagulation assays, massive transfusion (MT), ventilator-free days, and mortality were adjusted for confounders. Hyperfibrinolysis (HF) was defined as thromboelastogram of percent lysis in 30 min > 3%, and fibrinolysis shutdown was defined as percent lysis in 30 min < 0.9%. von Willebrand factor activity was quantified on 212 injured patients using a STAGO apparatus. Results: Overall, 268 patients met criteria. Type O patients were more likely to develop HF than non-type O blood patients (43% vs. 29%, P = 0.06) and had significantly lower vWF activity (222% vs. 249%, P = 0.01). After adjustment for New Injury Severity Score and blunt mechanism, type O had higher odds of HF (odds ratio, 1.94, 95% confidence interval, 1.09-3.47) and increased odds of MT (odds ratio, 3.02; 95% confidence interval, 1.22-7.49). Other outcomes were not significantly affected. Conclusion: Type O patients with hypotension had increased HF and MT post injury, and these were associated with lower vWF activity. These findings have implications for the monitoring of HF in patients receiving type O whole-blood transfusions post injury.
参考来源
- DeBot M, Eitel AP, Moore EE, et al. BLOOD TYPE O IS A RISK FACTOR FOR HYPERFIBRINOLYSIS AND MASSIVE TRANSFUSION AFTER SEVERE INJURY. Shock. 2022. PMID: 36548640. doi:10.1097/SHK.0000000000002013
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。